Literature DB >> 11231620

CYP3A genetics in drug metabolism.

M Eichelbaum, O Burk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231620     DOI: 10.1038/85417

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  26 in total

1.  Identification of regulatory sites in the human PXR (NR1I2) promoter region.

Authors:  Kouichi Kurose; Shinobu Ikeda; Satoru Koyano; Masahiro Tohkin; Ryuichi Hasegawa; Jun-ichi Sawada
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

2.  The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.

Authors:  Elisabet Størset; Kristine Hole; Karsten Midtvedt; Stein Bergan; Espen Molden; Anders Åsberg
Journal:  Br J Clin Pharmacol       Date:  2017-02-27       Impact factor: 4.335

3.  Genetic mediators of neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia.

Authors:  Kevin R Krull; Deepa Bhojwani; Heather M Conklin; Deqing Pei; Cheng Cheng; Wilburn E Reddick; John T Sandlund; Ching-Hon Pui
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

4.  Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.

Authors:  Hanna Nylén; Sofia Sergel; Lisa Forsberg; Synnöve Lindemalm; Leif Bertilsson; Katarina Wide; Ulf Diczfalusy
Journal:  Eur J Clin Pharmacol       Date:  2011-01-19       Impact factor: 2.953

5.  The far and distal enhancers in the CYP3A4 gene co-ordinate the proximal promoter in responding similarly to the pregnane X receptor but differentially to hepatocyte nuclear factor-4alpha.

Authors:  Fu-Jun Liu; Xiulong Song; Dongfang Yang; Ruitang Deng; Bingfang Yan
Journal:  Biochem J       Date:  2008-01-01       Impact factor: 3.857

6.  4β-hydroxycholesterol correlates with dose but not steady-state concentration of carbamazepine: indication of intestinal CYP3A in biomarker formation?

Authors:  Caroline Gjestad; Duy Khanh Huynh; Tore Haslemo; Espen Molden
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

7.  Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy.

Authors:  Katarina Wide; Hanna Larsson; Leif Bertilsson; Ulf Diczfalusy
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

Review 8.  Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.

Authors:  Hongbing Wang; Edward L LeCluyse
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Review of erlotinib in the treatment of advanced non-small cell lung cancer.

Authors:  Kristen N Ganjoo; Heather Wakelee
Journal:  Biologics       Date:  2007-12

10.  Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.

Authors:  Ehab S Eldesoky; Sherif I Kamel; Ahlam M Farghaly; Madiha Y Bakheet; Mohsen A Hedaya; Jean-Pascal Siest
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.